Vaccine Effectiveness against DS-1–Like Rotavirus Strains
Toyoko Nakagomi
Emerging Infectious Diseases · 2020
doi:10.3201/eid2601.191377 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
To the Editor: Global emergence of reassortant rotavirus A (RVA) strains possessing the DS-1 backbone genes, such as DS-1-like G1P[8] strains (1-3), raises 2 key questions of public health importance. First, is the G1P[8] monovalent vaccine (RV1) effective against the DS-1-like G1P[8] strain? Second, does this strain cause more severe disease than the Wa-like G1P[8] strain?
Abstract licence: CC BY
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.